[The risk of hypoglycemia in sulfonylurea therapy].
D000367:Age Factors; D000368:Aged; D001645:Biguanides / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000188:drug therapy; D004035:Diet Therapy; D005951:Glucose Tolerance Test; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000628:therapy; D008875:Middle Aged; D009461:Neurologic Manifestations; D012008:Recurrence; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
D001645:Biguanides; D013453:Sulfonylurea Compounds
Das Hypoglykämierisiko bei der Behandlung mit Sulfonylharnstoffen.